Lyell Immunopharma, Inc.
LYEL · Healthcare · $237M
$9.68+0.52%
Price
$12.97
$10.00
Jul 1, 26Sep 30, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$0M+100.0%
Operating Income-$2M+96.2%
Net Income-$45M-85.3%
3/'26 vs prev quarter
Company Health
Market Cap$237M
Operating Margin-542522.2%
Cash on Hand$204M86.0% of market cap
Free Cash Flow$-134M-56.5% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR8739.9xmedian 11.4xPBR1.0xmedian 2.0xROE-106.3%median -54.5%
